跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Salmetin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Salmetin
Approved
STANDARD
Salmetin
Jewin Pharmaceuticals (Shandong) Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
de9f58d2cfb76db2
Company
Jewin Pharmaceuticals (Shandong) Co., Ltd.
Type
Standard
Approval Details
Approval Id
de9f58d2cfb76db2
Drug Approval Philippines Name
Salmetin
Product Name
Salmetin
Registration Number
DR-XY42277
Brand Name
Salmetin
Generic Name
Salmeterol (as xinafoate) + Fluticasone Propionate
Dosage Form
Dry Powder For Inhalation In Capsule
Dosage Strength
50mcg/500mcg
Manufacturer
Jewin Pharmaceuticals (Shandong) Co., Ltd.
Importer
Global Pharmatrade
Distributor
Global Pharmatrade
Issuance Date
26 July 2023
Expiry Date
22 July 2028
Pharmacologic Category
Inhalation Cortiosteroid/Beta-2-Adrenoceptor Agonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
de9f58d2cfb76db2
Type
Standard
Back to Philippines FDA Approvals